# v1.10.1 Hygiene Cycle — Physical Merge of Delta Artifacts into Bundle File Bodies

**Cycle started:** 2026-05-02
**Authorization:** Evans's "use your recommended and go yolo mode" instruction 2026-05-02
**Workstream lead:** Evans (Product Lead, via Claude proxy)
**Adversarial reviewer:** Codex (gpt-5.5)
**Purpose:** Eliminate the dual-read requirement introduced in Phase 6 promotion (delta-artifact-supplement convention). Bundle file bodies receive the v1.10 cycle substantive content edits; delta artifacts in `Telecheck_v1_10_PRD_Update/` retain their authoritative-reference status for audit trail.

---

## Phase plan

| Phase | Files | Status |
|---|---|---|
| **A — Contracts Pack core (6 files)** | INVARIANTS, AUDIT_EVENTS, CCR_RUNTIME, TYPES, GLOSSARY, AI_LAYERING | in progress |
| **B — Contracts Pack remainder (4 files)** | DOMAIN_EVENTS, FORMS_ENGINE, GOVERNANCE_CONTROLS, MARKET_LAUNCH | pending |
| **C — Engineering specs (6 files)** | CDM, State Machines, OpenAPI, RBAC, System Architecture, Tenant Threading | pending |
| **D — Slice PRDs + OR Tracker + Other docs (~26 files)** | Phase 5 group 5A + 5D + 5E edits | pending |

After each phase: fire Codex group verification; patch; converge to 0/0; advance.

---

## Progress log

### Phase A — Contracts Pack core (in progress)

- **A1 INVARIANTS v5.2** — DONE. Removed v5.2 promotion-note-pointer header; appended I-029 (research data export gates), I-030 (consent-zero-impact on care delivery), I-031 (high_pii audit_sensitivity_level for research export events) full normative entries with three-gate rule, audit-side requirement, reject-unless mechanics. Doc-control v5.2 entry added.
- **A2 AUDIT_EVENTS v5.2** — DONE. Removed pointer header; expanded record schema with `ai_workload`, `audit_sensitivity_level`, `ai_workload_type`, `autonomy_level`, agentic-context fields (`agent_id`, `agent_version`, `tool_call_id`, `memory_read_set_id`, `memory_write_set_id`, `supervising_policy_id`, `knowledge_source_versions[]`); added Workload-taxonomy nullability + sensitivity rules; Enum coverage rule (active+reserved); Actor type addition; I-012 audit-side preservation rule; Research events table (6 events: research.consent_granted/revoked/dsa_activated/cohort_defined/export_initiated/export_completed) with high_pii sensitivity for export_*; I-029 binding for export_completed (two-event audit pattern); I-030 audit cross-check; Research export tenant-scope rule; Marketing events table (marketing.surface_rendered, marketing.surface_drift); Auto-suspension binding; 5 new anti-patterns. Doc-control v5.2 entry.
- **A3 CCR_RUNTIME v5.2** — DONE. Removed pointer header; appended marketing block (4 keys with embedded `marketing_copy_governance_evidence` structured object enforcing required-field completeness) and research block (7 keys including closed-enum `research_permitted_data_domains`, structured `research_ethics_review_body`, `cross_border_research_transfer_evidence` companion structured object); Initial-values per launch country table (US prohibited+consent_only; GH pending_evidence+consent_only); Reference to invariants section (I-029, I-030, I-031); marketing+research change-control rows (ADR-027 v0.5 triple sign-off + ADR-028 v0.4 quad sign-off). Doc-control v5.2 entry.
- **A4 TYPES v5.2** — DONE. Removed pointer header; inserted Marketing types (MarketingCopy, MarketingCopyGovernanceEvidence); Research data types (DataSharingAgreement, ResearchEthicsReviewBody, CohortDefinition, ResearchDataExport with `tenant_id` + `country_of_care` on the export record itself); AI workload types (AIWorkloadType + AutonomyLevel TypeScript enums + PolicyAuthorization placeholder); Program catalog types (ProgramCatalogEntry per Master PRD §10.5); 8 new ID prefixes (`mkc_`, `mge_`, `dsa_`, `reb_`, `chd_`, `rex_`, `pau_`, `prg_`). Doc-control v5.2 entry.
- **A5 GLOSSARY v5.2** — DONE. Removed pointer header; amended `tenant` (operating-tenant Telecheck-US/Telecheck-Ghana + DBA framing), `Mode 1` (workload taxonomy mapping line), `Mode 2` (workload taxonomy mapping + ADR-005 preservation), `platform_floor` (§13.7 v1.10 extension + I-029/I-030/I-031 floor extension); inserted 4 new sections — Brand and tenant terms (9 from C3 + C1), Marketing terms (4 from C4), Research data terms (10 from C5), AI taxonomy terms (14 from C7) — total 37 new terms; added forbidden-alias updates (Heros bare-name forbidden, §17 carve-outs, chatbot universally forbidden); 6 new anti-patterns. Doc-control v5.2 entry.
- **A6 AI_LAYERING v5.2** — DONE. Removed pointer header; appended §10 Future workload expansion per ADR-029 (§10.1 supersession scope, §10.2 Mode 1/Mode 2 ↔ taxonomy mapping, §10.3 ADR-002 + ADR-005 preservation, §10.4 I-012 preservation rule with full reject-unless three-clause normative wording, §10.5 AI scribe + lab interpretation classification). Two-mode architecture and §9 tenant scoping preserved. Doc-control v5.2 entry.

### Phase A complete — fired Codex Group 1A verification

All 6 Phase A files merged from delta artifacts into bundle bodies. Pointer headers removed; doc-control entries added; substantive content folded in.

**Codex Group 1A verification outcome:** returned with "No branch diff or repository changes provided to review" (null finding) — diff-based review requires committed state, but Phase A merges are on the working tree pending end-of-cycle commit. Per Evans's "yolo mode" authorization + "auto allow always from here", deferred Codex group reviews to a single end-of-cycle EXIT verification with parallel scoped reviews (per the multi-agent adoption decision below).

### Phase B complete — 4 Contracts Pack remainder files

- **B1 DOMAIN_EVENTS v5.2** — DONE. Removed pointer header. Added 4 research domain events (research_consent.granted/revoked, research_export.requested/delivered) per ADR-028 with full payload definitions; 2 marketing domain events (marketing.surface_published/suspended) per ADR-027; tenant-scope rule for research and marketing events; 3 new aggregates (research_consent, research_export, marketing_surface) with composite tenant_id:aggregate_id partition keys; I-029 binding; I-030 cascade prohibition; doc-control v5.2 entry.
- **B2 FORMS_ENGINE v5.2** — DONE. Removed pointer header. Added Research consent integration section per ADR-028 with L1 rendering gate / L4 approval governance / 6-category static analysis I-030 enforcement; cross-reference to Master PRD §10.5 program catalog architecture (Pattern A immutable per-market form versions); doc-control v5.2 entry.
- **B3 GOVERNANCE_CONTROLS v5.2** — DONE. Removed pointer header. Added §7 Research data export control envelope (CONFIG / INCIDENT / SIGNAL controls with audit-path discipline aligned with AUDIT_EVENTS v5.2 §5; bare suppression forbidden per I-003; 4 incident types — DSA expiry, k-anonymity violation, permitted-domain drift, consent revocation mid-export); §8 PolicyAuthorization framework placeholder per ADR-029 / future ADR-030; doc-control v5.2 entry.
- **B4 MARKET_LAUNCH v5.1** — DONE. Removed pointer header. Added Cross-reference to Master PRD §10.5 program catalog architecture (Program → ProgramMarketPolicy → Forms Engine instantiation → CCR Runtime resolution four-layer composition); Marketing posture activation gate per ADR-027 (6 conditions); Research data partnership activation gate per ADR-028 (11 conditions); doc-control v5.1 entry (note: MARKET_LAUNCH bumps v5.0 → v5.1, not v5.2).

### Phase C complete — 6 engineering specs

All 6 engineering specs received "v1.10 cycle additions" sections folded in from Phase 5 delta. None had pointer headers from the v1.10 promotion (engineering specs were untouched in the previous cycle's promotion).

- **C1 CDM v1.2** — DONE. Tenant entity gains `consumer_dba`, `legal_entity`, `consumer_subdomain` columns (C3 brand-structure); 6 new research data entities (ResearchConsent, CohortDefinition, DataSharingAgreement, ResearchEthicsReviewBody, ResearchPartner, ResearchDataExport); 1 new AIExecution entity (normative; unifies Mode 1+Mode 2 under workload taxonomy); 7 reserved-future entity names (Agent, AgentRun, Tool, ToolCall, AgentMemory, KnowledgeSource, PolicyAuthorization). Total entity count post-v1.10: 48 active + 7 reserved-future.
- **C2 State Machines v1.1** — DONE. 3 new research state machines per ADR-028 (ResearchConsent, DataSharingAgreement, ResearchExportRequest) with full I-029 reject-unless rule for `ready → delivered` and audit-side `status = invalidated` discipline; 1 new ProtocolAuthorizedAction state machine per ADR-029 with only `human_confirmed` path implemented as executable code at v1.0; reserved transitions documented as non-normative future sketches; I-012 three-clause reject-unless rule mirrored verbatim. Total state machines post-v1.10: 18 active + 4 reserved-future transitions.
- **C3 OpenAPI v0.2** — DONE. Tenant identifier sweep (Heros-Health → Telecheck-US per C3); 9 new research data endpoints (consent grant/revoke, cohort definition create/retrieve, export initiate/complete, DSA retrieve/activate, research audit retrieval) all tenant-scoped per I-023; export endpoints at high_pii per I-031. Total endpoints post-v1.10: 187 across 22 modules.
- **C4 RBAC v1.1** — DONE. Tenant Admin role examples reframed (Telecheck-US tenant admin (Heros Health DBA scope) etc.); 3 new research roles per ADR-028 (Research Data Steward, Research Ethics Committee Member, External Research Partner); activation gate signers documented for marketing posture and research data partnership.
- **C5 System Architecture v1.2** — DONE. §11.4 cross-border posture refresh with operating-tenant + DBA qualifier framing; new Research Data Export Module (16th module in architecture) implementing §15.3 4-layer pipeline (cohort definition → de-identification → aggregation → DSA enforcement); tenant-scoped per I-023; audit at high_pii per I-031; activation gated per MARKET_LAUNCH v5.1 + ADR-028 quad sign-off.
- **C6 Tenant Threading Addendum v1.0** — DONE. Mechanical tenant-ID sweep per C3 brand structure (Heros-Health → Telecheck-US with consumer-DBA qualifier where applicable); sender display names sourced from `tenant.consumer_dba`, never from `tenant.id`; symmetric refresh for Telecheck-Ghana / Heros Health Ghana; no semantic change to tenant-threading model.

### Multi-agent orchestration adoption (Evans authorized 2026-05-02 via "i agree")

After completing Phase C, the orchestrator (Claude proxy) recommended adopting tier-1 multi-agent expert workstream orchestration for the remainder of the v1.10.1 cycle. Evans authorized adoption with "i agree".

Workstream discipline note `Telecheck_Workstream_Discipline_Note_Multi_Agent_Orchestration_v0_1_DRAFT.md` drafted to capture the pattern. Distinguishes workstream-side multi-agent practice (this note) from product-side AI workload taxonomy (ADR-029) — the two are orthogonal. Pilot is the v1.10.1 hygiene cycle Phase D and Codex final EXIT review.

### Phase D — multi-agent fan-out (in progress)

6 sub-agents dispatched in parallel:
- **D1 — C2 emerging-markets reframe (5 slice rows)**: returned. 5 files edited (RPM/CCM, Herb-Drug, AE Reporting, Community Platform, Pharmacy+Refill). All edits clean; concrete pilot citations preserved per delta.
- **D2 — C3 brand structure cascade slices (4 rows)**: returned. 4 files edited (Market Rollout Cockpit, Admin Backend, Forms/Intake verify-only, Pharmacy/Refill verify-only). Resolved concurrent-edit race with D3/D4 additively.
- **D3 — C4 marketing posture (4 rows)**: returned. 4 files edited (Acquisition Engagement Tools, Forms/Intake, Admin Configuration Surfaces, Market Rollout Cockpit). Resolved concurrent-edit race with D2 additively.
- **D4 — C5 research + C6 program catalog (8 rows)**: still running.
- **D5 — C7 AI taxonomy (3 rows)**: returned. 2 unique files edited (AI Clinical Assistant Slice §3.1 + §13.4; Consent & Delegated Access Slice §17 verify marker). I-012 three-clause invariant mirrored verbatim.
- **D6 — DIC + Design + OR Tracker + Group 5E other docs + Group 5F country regulatory placeholders (largest batch)**: still running.

Concurrent-edit races between sub-agents on shared files (Market Rollout Cockpit, Forms/Intake, Pharmacy/Refill, Consent & Delegated Access) resolved additively under shared "v1.10 cycle additions" section headers with row-numbered subsections.

### Codex final EXIT (queued post-D4+D6 return)

Brief authored at `Codex_Final_v1_10_1_Hygiene_Cycle_Brief_2026-05-02.md`. 4 parallel scoped reviews:
1. Clinical safety (I-012 / autonomy levels / ADR-002 / ADR-005 / §13.7 single normative source / reserved-transition discipline)
2. Privacy (I-029 / I-030 / I-031 / failed-export audit-path discipline / 5th consent tier asymmetric retraction)
3. Regulatory (ADR-027 / ADR-028 activation gates / CCR initial values per launch country / cross-border transfer evidence)
4. Brand structure C3 (Telecheck-{country} naming / Heros Health DBA sourcing / chatbot universally forbidden / Mode 1+2 ↔ taxonomy mapping with code-vs-UI rule)
